Use of Sodium Bicarbonate As Prophylaxis for Kidney Damage in Patients with Heatstroke

NCT ID: NCT06622525

Last Updated: 2024-10-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-01

Study Completion Date

2025-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study protocol aims to prevent the need for renal replacement therapy in patients with rhabdomyolysis secondary to heatstroke. It is based on previous studies showing that bicarbonate infusion reduces renal failure in similar contexts. The intervention will be conducted at the General Hospital of Mexicali during the summer, targeting the prevention of renal failure and reducing the necessity for renal replacement therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The present study protocol explores the possibility of preventing the need for renal replacement therapy in patients who develop rhabdomyolysis secondary to heatstroke. This is based on previous studies that have used bicarbonate infusion in the context of rhabdomyolysis secondary to compartment syndrome, finding a lower incidence of renal failure. Due to the aforementioned, we propose to carry out a similar intervention at the General Hospital of Mexicali, where there is a significant incidence of heatstroke during the summer months. The aim is to determine whether this intervention is useful in preventing the development of renal failure and the requirement for renal replacement therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heat Stroke Acute Kidney Injury Acute Kidney Injury Due to Hypovolaemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized, open-label clinical trial at the General Hospital of Mexicali; central tendency measures will be obtained for variables.
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

This group will receive 100 mEq of sodium bicarbonate diluted in one liter of saline solution, administered at a rate of 100 ml/h, with the goal of maintaining a urinary pH greater than 6.5.

Group Type EXPERIMENTAL

Sodium bicarbonate

Intervention Type DRUG

This group will receive 100 mEq of sodium bicarbonate diluted in one liter of saline solution, administered at a rate of 100 ml/h, with the goal of maintaining a urinary pH greater than 6.5.

Control Group

This group will be manage with the usual care that is given to patients with heat stroke in this hospital.

Group Type ACTIVE_COMPARATOR

No intervention

Intervention Type OTHER

The usual management for heat stroke will be given to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sodium bicarbonate

This group will receive 100 mEq of sodium bicarbonate diluted in one liter of saline solution, administered at a rate of 100 ml/h, with the goal of maintaining a urinary pH greater than 6.5.

Intervention Type DRUG

No intervention

The usual management for heat stroke will be given to this group

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Control Group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admitted to the General Hospital of Mexicali with the diagnosis of heat stroke.
* Meeting the operational definition (exposure to heat, body temperature at admission greater than 40 degrees Celsius).
* CPK level greater than 1000 U/L.
* Having informed consent from the patient or the legally responsible adult.

Exclusion Criteria

* Exclusion of the heat stroke diagnosis during their evaluation.
* Lack of serum creatinine levels at the time of admission to the protocol.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidad Autonoma de Baja California

OTHER

Sponsor Role collaborator

Hospital General de Mexicali

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hiram J Jaramillo Ramirez, MD

Role: PRINCIPAL_INVESTIGATOR

Hospital General de Mexicali

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital General de Mexicali

Mexicali, Estado de Baja California, Mexico

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Mexico

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joaquin Cordova Erberk, MD

Role: CONTACT

+52 653 132 0309

Hiram J Jaramillo Ramirez, MD

Role: CONTACT

+52 653 132 0309

References

Explore related publications, articles, or registry entries linked to this study.

Bouchama A, Knochel JP. Heat stroke. N Engl J Med. 2002 Jun 20;346(25):1978-88. doi: 10.1056/NEJMra011089. No abstract available.

Reference Type BACKGROUND
PMID: 12075060 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HGMexicali

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.